SC
Sharon Cohen-Vered
Vp Cmc at Neurosense Therapeutics
View Sharon's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Vp Cmc
2020 - Present · 5 years
Raziel Therapeutics
Vp Cmc
2019 - Present · 6 years
NA
Cmc Consultant
2008 - Present · 17 years
Company Details
11-50 Employees
Advancing research, development and therapy for ALS and additional CNS indications.
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) is a clinical stage Biotech company focusing on the development of a ground-breaking treatment for ALS patients, as well as other neurodegenerative diseases.
Currently in conducting a Phase 2b, double-blind, randomized, placebo controlled clinical study in ALS patients globally.
$NRSN
Website
Year Founded
2017
Social Media
LinkedinFacebookTwitter
Industry
Biotechnology Research
HQ Location
1 Broadway
Cambridge, Massachusetts 02142, US
Keywords
Drug DevelopmentALSMNDLou Gehrig's DiseaseCNSBiopharmaceuticalsNeurodegenerative DiseasesParkinson's DiseaseAlzheimer's diseaseNovel treatment
Contact Details
- Email AddressS**@neurosense-tx.comReveal Email
- Phone Number(xxx)xxx-xxxxReveal Phone
Find verified contacts of Sharon Cohen-Vered in seconds from 700M people profiles. Start now!
Continue with GoogleNo Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.